Retracted: Applications and advances of CRISPR-Cas9 in cancer immunotherapy

An-Liang Xia, Qi-Feng He, Jin-Cheng Wang, Jing Zhu, Ye-Qin Sha, Beicheng Sun, Xiao-Jie Lu

Open source

DOI
10.1136/jmedgenet-2018-105422
Published
2018-07-03
Container
Journal of Medical Genetics
Publisher
BMJ
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jmedgenet-2018-105422,
  title = {Retracted: Applications and advances of CRISPR-Cas9 in cancer immunotherapy},
  author = {An-Liang Xia and Qi-Feng He and Jin-Cheng Wang and Jing Zhu and Ye-Qin Sha and Beicheng Sun and Xiao-Jie Lu},
  year = {2018},
  journal = {Journal of Medical Genetics},
  doi = {10.1136/jmedgenet-2018-105422},
  url = {https://doi.org/10.1136/jmedgenet-2018-105422}
}

RIS

TY  - JOUR
TI  - Retracted: Applications and advances of CRISPR-Cas9 in cancer immunotherapy
AU  - An-Liang Xia
AU  - Qi-Feng He
AU  - Jin-Cheng Wang
AU  - Jing Zhu
AU  - Ye-Qin Sha
AU  - Beicheng Sun
AU  - Xiao-Jie Lu
PY  - 2018
JO  - Journal of Medical Genetics
DO  - 10.1136/jmedgenet-2018-105422
UR  - https://doi.org/10.1136/jmedgenet-2018-105422
ER  - 

APA

Xia, A., He, Q., Wang, J., Zhu, J., Sha, Y., Sun, B., & Lu, X. (2018). Retracted: Applications and advances of CRISPR-Cas9 in cancer immunotherapy. Journal of Medical Genetics. https://doi.org/10.1136/jmedgenet-2018-105422

Source records